Endocyte, Inc. (NASDAQ:ECYT) Signs Licensing Agreement

Endocyte, Inc. (NASDAQ:ECYT) Signs Licensing Agreement”

Endocyte, Inc. (NASDAQ:ECYT) recently saw its volume around 0.2 million shares and on average it trades 360.56 million shares a day. The stock has "Outperform" rating by Credit Suisse on Thursday, January 21.

Company shares are trading at $5.50 which is well above $1.42, the 50 day moving average and significantly higher than the 200 day moving average of $1.83. Of those analysts, no rate stock as a Strong Buy, 2 rate it as Hold, and just no analyst rates it as a Moderate Sell.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 0, and a price to sales ratio of 0.33. Endocyte had 7 analyst reports since August 5, 2015 according to SRatingsIntel. (NASDAQ:ECYT) hit a new 52-week high and has $6.17 target or 6.00 % above today's $5.82 share price. Now trading with a market value of 154.29M, the company has a mix of catalysts and obstacles that spring from the nature of its operations.

This stock (ECYT) is ahead of its 52-week low with 20.51%. (NASDAQ:ECYT) were released by: and their article: "Options Traders Expect Huge Moves in Endocyte (ECYT) Stock" published on October 03, 2017 as well as's news article titled: "Endocyte Announces Exclusive Worldwide License of Phase 3 Ready PSMA-Targeted ..." with publication date: October 02, 2017.

Endocyte, Inc. (NASDAQ:ECYT) shares have traded 159.29% for the week and are 42.35% for the year. The forecast of 0 surveyed investment analysts covering the stock advises investors to Buy stake in the company. The company's net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin. Over the past month the firm's stock is 40.99%, 118.27% for the last quarter, 127.00% for the past six-months and 86.07% for the a year ago. If Endocyte, Inc. (NASDAQ:ECYT) shares can stay above the price resistance around $4.38 a share, that could help propel Endocyte, Inc. The original version of this report can be read at

Inclusion of study data that describe the time-action profile by dosage strength, showing first measurable effect starts in around 12 minutes, peak effects occur around 35 to 45 minutes after dosing and return to baseline after around 1.5 to 3 hours for the 4 and 12 unit cartridges respectively. Its Average True Range (ATR) value figured out at 0.57. With 246,900 avg volume, 3 days are for Arcbest Corporation (NASDAQ:ARCB)'s short sellers to cover ARCB's short positions. Dimensional Fund Advisors LP now owns 98,313 shares of the biopharmaceutical company's stock worth $147,000 after acquiring an additional 25,003 shares during the last quarter. The stock now has Weekly Volatility of 28.62% and Monthly Volatility of 9.84%. RMB Capital Management LLC raised its position in shares of Endocyte by 8.8% in the 1st quarter.

11/04/2015 - Endocyte, Inc. had its "outperform" rating reiterated by analysts at RBC Capital.

According to Endocyte, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 28.79%.

Like this


04 October 2017
Time Warner Inc. (TWX) Stake Decreased by Icon Advisers Inc
The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. Making effort to connect all the dots together to form a complete picture of how investors should approach these stocks.

04 October 2017
Microsoft Starts Rolling Out Windows 10 Fall Creators Update 16299.15 (Likely RTM)
As with all the recent Insider builds, there are not any new features to report, and no specific issues are addressed. Microsoft doesn't like to use terms like Release Candidate (RC) or Release to Manufacturing (RTM) anymore.

04 October 2017
French Ads Now Required to Disclose if a Model Has Been Photoshopped
The new law only prohibits the adjustment of body shape and will not be applied to retouched hair or skin. Rule-breakers of the new French law on model body modifying in photos could face a fine of up to $44,000.

04 October 2017
Sterling Bancorp (STL) Shares Bought by JPMorgan Chase & Co
Sterling National Bank provides various banking and financial products and services primarily in New York, New Jersey, and CT . Finally, LS Investment Advisors LLC boosted its holdings in shares of Sterling Bancorp by 33.5% during the first quarter.

04 October 2017
Tyra Banks and Boyfriend Erik Asla Call it Quits After 5 Years
In fact, he is set to shoot the opening credits for the upcoming season of Tyra's hugely popular reality competition, America's Next Top Model .

03 October 2017
Motive unknown in Las Vegas attack — WHAT'S HAPPENING
My hope is that sanity will prevail, and Republican leadership in Congress will muster up the courage to act". It is long past time to fix our gun laws. "You know my heart goes out to them", he said.

03 October 2017
Victim of Las Vegas shooting was celebrating anniversary
Parker was among four department employees who were attending the Route 91 Harvest Festival while off-duty. They said he was a heavy-duty mechanic apprentice and about to start trade school.

03 October 2017
Harbor Spring Capital LLC Lowers Stake in Cognizant Technology Solutions Corporation (CTSH)
The Financial Services segment includes clients providing banking/transaction processing, capital markets and insurance services. CHINTAMANENI RAMAKRISHNA PRASAD also sold $3.19M worth of Cognizant Technology Solutions Corp (NASDAQ:CTSH) on Monday, May 15.

03 October 2017
Should You Sell Newmont Mining Corporation Based On Current Broker Views?
As per Thursday, June 29, the company rating was maintained by Credit Suisse. (NYSE:CIT) on Monday, March 28 to "Neutral" rating. Following the transaction, the executive vice president now owns 82,114 shares of the company's stock, valued at $3,142,502.78.

03 October 2017
Zogenix, Inc. (NASDAQ:ZGNX), Wal-Mart Stores, Inc. (NYSE:WMT)
Shares for $237.76M were sold by WALTON JIM C. $868,299 worth of stock was sold by Gearhart Jeffrey J on Wednesday, May 24. The company has a market capitalization of $234.35 billion, a price-to-earnings ratio of 18.85 and a beta of 0.29.